ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MTFB Motif Bio Plc

0.50
0.00 (0.00%)
13 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.50 0.40 0.55 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Motif Bio Share Discussion Threads

Showing 2401 to 2421 of 9925 messages
Chat Pages: Latest  97  96  95  94  93  92  91  90  89  88  87  86  Older
DateSubjectAuthorDiscuss
25/5/2018
16:14
Nice big buy on my heals as well, roll on next week and Trump saying something nice :)
rathean
25/5/2018
15:47
That's me back in at 30.6, remarkable price considering the stage this pharma is at.
rathean
25/5/2018
08:04
I am a bit wary of CROs, having done some work for one of them, and having experienced things in the sector.
I would imagine we are using a CRO or another consultancy for this submission to the FDA and the consultants will be trying to get as much money as possible out of this.
I know that we need to get it 'right', but in the end, the FDA/EMA are actively encouraging new antibiotics, to refuse it because something is in the wrong font, there are two spaces after full stops rather than one (I have some experience of medical writing) and trivial stuff like that, or because something is missing, needs more analysis and they will not accept the information later, would be a PR disaster for the people working at the FDA/EMA.
So please get the submission in, don't worry about all the finer details, fulfilling the basic requirements are the important things. Provide the evidence that it has gone through trials, it is safe and equally efficacious to vancomycin in ABSSSI, with potentially less renal side effects.
Ask what the expert reviewers would want to see, check it is in the submission, and send it off.
Health services need iclaprim as another alternative. And it is then for us to decide what price we (would like to) charge and how we pitch it in the market, in negotiations later of course, but get it approved!!

gclark
24/5/2018
08:00
Interesting that AMP offloaded 2.9999% to US investor. Those Yanks aren't normally shy retiring types that like to keep under the radar for no good reason......
blueblood
23/5/2018
08:55
You will have a bloody long wait then!
blueblood
23/5/2018
08:55
These streets are paved with gold.
encarter
23/5/2018
08:52
No. Waiting for blood in the streets.
pretax2
23/5/2018
08:37
Just here for fun then?
small crow
23/5/2018
08:31
In MTFB? I’m not investing
pretax2
23/5/2018
08:29
If you think its inconsequential maybe you shouldn't be investing...
blueblood
23/5/2018
07:46
This is good news, at least we don't have to worry about AMP dumping shares on the open market which indeed would have been a major drag on the share price. Selling to a US investor should give us a much needed lift.
t-trader
23/5/2018
07:44
AMP are selling because they need the cash and had a chance to sell a big chunk of their stock which they would have trouble dumping onto the market. Let's hope they find a buyer for the rest and F OFF.
encarter
23/5/2018
07:27
Good news that AMP have sold big chuck to US investors
blueblood
23/5/2018
07:21
Interesting that a US investment house has taken a big chunk here, they can see the upside from these prices.
rathean
22/5/2018
17:52
Surely we will get news that the NDA has been submitted to the FDA any day now
return_of_the_apeman
22/5/2018
17:24
It's a puzzle for sure. Could it be Sandgrove accumulating again?
kspine
22/5/2018
16:51
Why would anyone sell nearly 9m shares at placing price?
blueblood
21/5/2018
15:27
Ŕeturned to the placing price so have picked up some more
return_of_the_apeman
21/5/2018
13:22
Except for the share price itself...
rizler
21/5/2018
11:52
Think I worked out support at about 30p. If it holds, company has prob with cash burn.
pretax2
21/5/2018
09:04
That's me in with a nibble of 17500. Support at these levels, well funded with FDA approval in Q2 of this year after 2 successful phase 3 trials.
rathean
Chat Pages: Latest  97  96  95  94  93  92  91  90  89  88  87  86  Older

Your Recent History

Delayed Upgrade Clock